|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.55 TWD | +1.28% |
|
-2.57% | -33.10% |
| 14/03 | Tanvex BioPharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 06/02 | Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer | CI |
Tanvex BioPharma USA, Inc. announced the change of corporate governance officer. Name, title, and resume of the previous position holder: Dr. Yun Yen /Tanvex Biopharma, Inc. Chairman/CEO/Chief/Spokesperson. Name, title, and resume of the new position holder: corporate governance officer: Hsuan Chang Li/Senior Director of Finance.
Effective date is December 21, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.10% | 22Cr | |
| +5.66% | 11TCr | |
| +11.23% | 11TCr | |
| -0.38% | 2.23TCr | |
| -12.15% | 2.21TCr | |
| -7.66% | 1.87TCr | |
| -36.52% | 1.76TCr | |
| -10.09% | 1.69TCr | |
| +3.33% | 1.38TCr | |
| +36.58% | 1.25TCr |
TANVEX BIOPHARMA, INC. 